InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by EVNIN ANTHONY B, Director. Director active across 3 companies, notably Cantel Medical CORP. In total, 6 reports have been recorded. History available since 2 June 2021. The latest transaction was disclosed on 19 January 2023 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
41,841 shares@ US$15.00100.0% of flowCommon StockSEC:0000899243-23-002193:0
46,378 shares@ US$0.67963.4% of flowCommon StockSEC:0001140361-22-023338:0
3,061 shares@ US$3.4318.3% of flowCommon StockSEC:0001140361-21-020643
3,061 shares@ US$3.4318.3% of flowCommon StockSEC:0001140361-21-020643:0
12,132 shares@ US$80.5950.0% of flowCommon Stock, par value $.10 per shareSEC:0001104659-21-075850
12,132 shares@ US$80.5950.0% of flowCommon Stock, par value $.10 per shareSEC:0001104659-21-075850:0
6 of 6 declarations
About EVNIN ANTHONY B
Anthony B. Evnin is a Board Member at Cantel Medical Corp and Infinity Pharmaceuticals, Inc. In this role, he actively participates in board discussions and contributes to strategic decision-making. His experience in the medical sector allows him to provide valuable insights on risk management and the company's growth. He is committed to promoting effective governance and ensuring the company's sustainability.
